Beaton Management Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,150
| Closed | -$212K | – | 136 |
|
|
2024
Q3 | $212K | Buy |
+2,150
| New | +$212K | 0.11% | 133 |
|
|
2022
Q1 | – | Sell |
-2,190
| Closed | -$245K | – | 147 |
|
|
2021
Q4 | $245K | Hold |
2,190
| – | – | 0.15% | 129 |
|
|
2021
Q3 | $275K | Hold |
2,190
| – | – | 0.18% | 117 |
|
|
2021
Q2 | $297K | Hold |
2,190
| – | – | 0.19% | 112 |
|
|
2021
Q1 | $297K | Hold |
2,190
| – | – | 0.21% | 106 |
|
|
2020
Q4 | $308K | Sell |
2,190
-60
| -3% | -$8.44K | 0.23% | 100 |
|
|
2020
Q3 | $251K | Hold |
2,250
| – | – | 0.21% | 102 |
|
|
2020
Q2 | $252K | Buy |
+2,250
| New | +$252K | 0.22% | 97 |
|
|
2020
Q1 | – | Sell |
-2,250
| Closed | -$214K | – | 121 |
|
|
2019
Q4 | $214K | Buy |
+2,250
| New | +$214K | 0.17% | 118 |
|
|
2019
Q3 | – | Sell |
-2,300
| Closed | -$202K | – | 122 |
|
|
2019
Q2 | $202K | Sell |
2,300
-100
| -4% | -$8.78K | 0.17% | 115 |
|
|
2019
Q1 | $217K | Buy |
+2,400
| New | +$217K | 0.19% | 113 |
|
|
2018
Q4 | – | Sell |
-2,350
| Closed | -$225K | – | 120 |
|
|
2018
Q3 | $225K | Buy |
2,350
+50
| +2% | +$4.79K | 0.19% | 113 |
|
|
2018
Q2 | $219K | Buy |
+2,300
| New | +$219K | 0.2% | 113 |
|